VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,569,000 | +46.2% | 67,459 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $1,073,000 | -24.0% | 67,459 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,411,000 | +259.9% | 67,459 | +150.3% | 0.00% | – |
Q4 2016 | $392,000 | -68.5% | 26,954 | -46.6% | 0.00% | -100.0% |
Q3 2016 | $1,245,000 | -52.1% | 50,491 | -61.0% | 0.00% | -66.7% |
Q2 2016 | $2,599,000 | -55.7% | 129,586 | -26.2% | 0.00% | -57.1% |
Q1 2016 | $5,864,000 | -76.5% | 175,577 | -3.3% | 0.01% | -75.0% |
Q4 2015 | $24,959,000 | -25.4% | 181,585 | +26.9% | 0.03% | -30.0% |
Q3 2015 | $33,447,000 | -52.3% | 143,146 | -44.4% | 0.04% | -46.7% |
Q2 2015 | $70,118,000 | +28.1% | 257,236 | -6.6% | 0.08% | +21.0% |
Q1 2015 | $54,727,000 | +58.8% | 275,538 | +14.4% | 0.06% | +63.2% |
Q4 2014 | $34,454,000 | -48.7% | 240,754 | -52.9% | 0.04% | -53.1% |
Q3 2014 | $67,125,000 | +2.0% | 511,623 | -1.9% | 0.08% | -2.4% |
Q2 2014 | $65,777,000 | +7.6% | 521,542 | +12.4% | 0.08% | +13.7% |
Q1 2014 | $61,145,000 | +26.2% | 463,816 | +12.4% | 0.07% | +17.7% |
Q4 2013 | $48,452,000 | +211.3% | 412,713 | +176.7% | 0.06% | +195.2% |
Q3 2013 | $15,563,000 | +57.7% | 149,167 | +30.1% | 0.02% | +50.0% |
Q2 2013 | $9,867,000 | – | 114,634 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |